Science & Enterprise subscription

Follow us on Twitter

  • Vietnam War Memorial #flickr https://t.co/VwB3z4ZQrF ... photo from #MemorialDay 2010 ... @jaketapper
    about 5 hours ago
  • A therapy program for depression designed to reduce spirals of repeated negative thinking is licensed to a digital… https://t.co/Op6EDZgwpS
    about 12 hours ago
  • New post on Science and Enterprise: Depression Therapy Licensed for Online Distribution https://t.co/pKWAsbbhAu #Science #Business
    about 12 hours ago
  • The Federal Reserve, the U.S. central bank, released statistics showing in April 2020, manufacturing output dropped… https://t.co/q390P26pNf
    about 3 days ago
  • New post on Science and Enterprise: Infographic – Largest Ever U.S. Manufacturing Decline https://t.co/WkZSpIfnoj #Science #Business
    about 3 days ago

Please share Science & Enterprise

Stem Cell Therapy Licensed for Genetic Eye Disease

Red-blue-green eye

A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease

Vaccine Blocks Suspected Type 1 Diabetes Infections

Syringe

A candidate vaccine is shown in lab animals to produce a strong immune response against a virus causing a range of diseases, and possibly blocking type 1 diabetes. . . . → Read More: Vaccine Blocks Suspected Type 1 Diabetes Infections

Synthetic Antibody Limits M.S. Inflammation

Neurons

An artificial antibody is shown in lab mice to reduce inflammation similar to multiple sclerosis in the brain and activate myelin cells in the spinal cord. . . . → Read More: Synthetic Antibody Limits M.S. Inflammation

[Updated] Fast Paper Strip Covid-19 Test Devised with Crispr

Sherlock paper test strips

A simple, fast test for Covid-19 infections with treated paper dipped in specimens is being created with the gene-editing technology Crispr. . . . → Read More: [Updated] Fast Paper Strip Covid-19 Test Devised with Crispr

Microsoft, Biotech Examine Covid-19 Immune Response

T-cells illustration

A study is enrolling home-bound participants to learn more about the response of T-cells in the immune system to SARS-CoV-2 viruses causing Covid-19 infections. . . . → Read More: Microsoft, Biotech Examine Covid-19 Immune Response

Biotech Gains Antibody Discovery, Manufacturing Funds

Global Covid-19

A Canadian biotechnology company is receiving government funds for Covid-19 antibody discovery and manufacturing for current and future pandemics. . . . → Read More: Biotech Gains Antibody Discovery, Manufacturing Funds

Oxford, AstraZeneca Partner on Covid-19 Vaccine

Covid-19 vaccine infographic

AstraZeneca agreed today to help develop, manufacture, and distribute a candidate vaccine to prevent Covid-19 infections designed by University of Oxford. . . . → Read More: Oxford, AstraZeneca Partner on Covid-19 Vaccine

Limited Covid-19 Benefits Found for Arthritis Drug

Coronavirus face mask

A clinical trial testing an arthritis drug to treat Covid-19 patients shows the drug helps the most critical patients, but not others with advanced infections. . . . → Read More: Limited Covid-19 Benefits Found for Arthritis Drug

Trial Okayed in Germany for Covid-19 Vaccine

SARS-Cov-2 virus

Regulators in Germany cleared a clinical trial to begin testing a vaccine with synthetic RNA to prevent coronaviruses from causing Covid-19 infections. . . . → Read More: Trial Okayed in Germany for Covid-19 Vaccine

Fast, Simple Covid-19 Antibody Test Being Developed

Plasmonic fluor illustration

An engineering lab is creating an easy-to-use test of immune-system antibodies to the SARS-Cov-2 virus responsible for Covid-19 infections. . . . → Read More: Fast, Simple Covid-19 Antibody Test Being Developed